Post Injection Syndrome with Olanzapine Long Acting Injectable in a patient with Schizophrenia

被引:0
|
作者
Sahoo, Surjeet [1 ]
Kamilya, Sayari [1 ]
Gupta, Alok [1 ]
机构
[1] Inst Med Sci & SUM Hosp, Bhubaneswar, India
关键词
D O I
暂无
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
引用
收藏
页码:S145 / S145
页数:1
相关论文
共 50 条
  • [21] Post-injection delirium/sedation syndrome after olanzapine long-acting injection: Experience of the Milan Poison Center
    Panzavolta, Giscardo F.
    Stella, Andrea F.
    Zuccoli, Maria L.
    Tomoiaga, Adriana M.
    Travaglia, Angelo
    Sesana, Fabrizio
    Davanzo, Franca
    CLINICAL TOXICOLOGY, 2015, 53 (04) : 395 - 395
  • [22] A study on blood pressure changes following Olanzapine Long Acting Injection (LAI) in schizophrenia
    Gakkhar, Shivam
    Satapathy, Ramanand
    INDIAN JOURNAL OF PSYCHIATRY, 2022, 64 (SUPPL 3) : S604 - S604
  • [23] A study on blood pressure changes following Olanzapine Long Acting Injection (LAI) in schizophrenia
    Gakkhar, Shivam
    Satapathy, Ramanand
    INDIAN JOURNAL OF PSYCHIATRY, 2022, 64
  • [24] Profile of olanzapine long-acting injection for the maintenance treatment of adult patients with schizophrenia
    Di Lorenzo, Rosaria
    Brogli, Alice
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2010, 6 : 573 - 581
  • [25] Assessing the infrequent oral supplementation of olanzapine long-acting injection in the treatment of schizophrenia
    Ascher-Svanum, H.
    Peng, X.
    Montgomery, W.
    Faries, D. E.
    Lawson, A. H.
    Witte, M. M.
    Novick, D.
    Jemiai, N.
    Perrin, E.
    McDonnell, D. P.
    EUROPEAN PSYCHIATRY, 2011, 26 (05) : 313 - 319
  • [26] COST-EFFECTIVENESS ANALYSIS OF OLANZAPINE LONG-ACTING INJECTION COMPARED WITH RISPERIDONE LONG-ACTING INJECTION IN THE TREATMENT OF SCHIZOPHRENIA IN NORWAY
    Carroll, S. M.
    Jemiai, N.
    Suter, B.
    O'Donohoe, P.
    Skjoldborg, U.
    Moller, J.
    Kleivenes, O. K.
    Novick, D.
    VALUE IN HEALTH, 2009, 12 (07) : A358 - A358
  • [27] Switching Patients with Stable Schizophrenia or Schizoaffective Disorder from Olanzapine to Risperidone Long-Acting Injectable
    Rosa, Fernanda
    Schreiner, Andreas
    Thomas, Pierre
    Sherif, Tarek
    CLINICAL DRUG INVESTIGATION, 2012, 32 (04) : 267 - 279
  • [28] QUALITY OF LIFE AND PATIENT-REPORTED OUTCOMES: COMPARISONS OF INDIVIDUALS WITH SCHIZOPHRENIA TREATED WITH ORAL AND LONG-ACTING INJECTABLE FORMULATIONS OF OLANZAPINE
    Godfrey, J. L.
    Detke, H. C.
    Montgomery, W. S.
    Zhao, F.
    McDonnell, D.
    VALUE IN HEALTH, 2009, 12 (07) : A363 - A363
  • [29] Patient satisfaction and caregiver burden related to olanzapine long-acting injection
    Mcdonnell, D.
    Detke, H.
    Liu, C.
    Moore, K.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2012, 15 : 125 - 126
  • [30] Switching Patients with Stable Schizophrenia or Schizoaffective Disorder from Olanzapine to Risperidone Long-Acting Injectable
    Fernanda Rosa
    Andreas Schreiner
    Pierre Thomas
    Tarek Sherif
    Clinical Drug Investigation, 2012, 32 : 267 - 279